CD8A and neoplasm: Continuous HIV antigen stimulation persists even in patients receiving antiretroviral therapy, resulting in the tumor-specific CD8+ T cells becoming positive cells of CTLA-4 through the influence of continuously activated HIV-specific CD8+ T cells [25].